MYRIAD GENETICS (MYD BE) stock market data APIs
€3.993
0(0%)
as of March 16, 2026
Try our APIs with
free plan!
MYRIAD GENETICS Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for MYD.BE.
Prev. Close
3.993
Open
3.993
High
3.993
Low
3.993
52 wk Range
3.32-9.25
Market Cap
1 751 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get MYRIAD GENETICS data using free add-ons & libraries
Get MYRIAD GENETICS Fundamental Data
MYRIAD GENETICS Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-02-23
- EPS/Forecast: -0.02
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
MYRIAD GENETICS News
New
Six presented abstracts at ASCO-GU 2026 reinforce the clinical impact of Myriad’s Precise MRD, Prolaris, and MyRisk tests
Myriad Genetics, Inc. SALT LAKE CITY, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will present new data a...
MYGN Stock Up on Q4 Earnings and Revenue Beat, Gross Margin Down
Myriad Genetics, Inc. MYGN reported fourth-quarter 2025 adjusted earnings of 4 cents per share, which surpassed the Zacks Consensus Estimate by 350% and increased 33.3% year over year. Adjusted ear...
Myriad Genetics Inc (MYGN) Q4 2025 Earnings Call Highlights: Surpassing Revenue Expectations ...
This article first appeared on GuruFocus. Fourth Quarter Revenue: $210 million, above the high end of the pre-announced range. Full Year 2025 Revenue: $824.5 million. Fourth Quarter Test Volume: 382,...
Here's What Key Metrics Tell Us About Myriad (MYGN) Q4 Earnings
For the quarter ended December 2025, Myriad Genetics (MYGN) reported revenue of $209.8 million, down 0.4% over the same period last year. EPS came in at $0.04, compared to $0.03 in the year-ago quarte...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
